‘Standardized’ Comment From Brexit Minister Raises Hopes For Parallel EU/UK Drug Approval System

The way in which pharmaceuticals might be regulated in the UK after the country leaves the EU is a big unknown. As MPs get to have their say on the matter, the Pink Sheet tries to gauge government thinking.